This content will become publicly available on March 5, 2025
Heparin Specifically Inhibits CRISPR/Cas12 Activation, Enabling Ultrasensitive Heparin Detection and Gene Editing Regulation
- Award ID(s):
- 1933525
- NSF-PAR ID:
- 10505592
- Publisher / Repository:
- ACS Publications
- Date Published:
- Journal Name:
- Analytical Chemistry
- Volume:
- 96
- Issue:
- 9
- ISSN:
- 0003-2700
- Page Range / eLocation ID:
- 3970 to 3978
- Format(s):
- Medium: X
- Sponsoring Org:
- National Science Foundation
More Like this
-
Ionically complexed nanoparticles were prepared from an anionic polysaccharide drug, heparin, entrapped by a positively charged chitosan polysaccharide. In this study, the encapsulation of heparin was studied to optimize properties needed for its oral drug delivery. Chitosan, used in a variety of biomedical applications, was selected as a cationic polymer for heparin encapsulation. These particles were prepared with a slightly positive charge and an appropriate size for oral drug delivery. The release profiles of these ionically complexed nanoparticles were improved by using FDA approved stabilizers, such as pluronic non-ionic surfactant and polyvinyl alcohol. These results obtained in vitro suggest that these stabilized, ionically complexed nanoparticles may be well-suited for the oral drug delivery of heparin into the gastrointestinal tract.more » « less